Pinote, Melinda D.

HRN: 27-17-20  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/20/2025
CLINDAMYCIN 300MG (CAP)
05/20/2025
05/26/2025
PO
300mg
Qid
Infected Wound
Waiting Final Action 
05/20/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/20/2025
05/26/2025
IV
600 Mg
Q 6 Hrs
Infected Wound
Waiting Final Action 
05/20/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/20/2025
05/26/2025
IV
750 Mg
Q 8 Hours
Infected Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: